|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-11-10
|
|
pubmed:abstractText |
To assess whether differences in safety profiles between nevirapine (NVP) and efavirenz (EFV), as observed in the 2NN study, translated into differences in 'health related quality of life' (HRQoL).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
721-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15535409-Adult,
pubmed-meshheading:15535409-Anti-HIV Agents,
pubmed-meshheading:15535409-Benzoxazines,
pubmed-meshheading:15535409-Drug Therapy, Combination,
pubmed-meshheading:15535409-Female,
pubmed-meshheading:15535409-HIV Infections,
pubmed-meshheading:15535409-Humans,
pubmed-meshheading:15535409-Male,
pubmed-meshheading:15535409-Nevirapine,
pubmed-meshheading:15535409-Oxazines,
pubmed-meshheading:15535409-Quality of Life,
pubmed-meshheading:15535409-Reverse Transcriptase Inhibitors,
pubmed-meshheading:15535409-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenz.
|
|
pubmed:affiliation |
Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. f.vanleth@iatec.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
